KINDRA MOORE: Open Payments
NPI 1447601703 · WILLINGBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 33 payments from 14 companies in 2025. Trend: 2023 $1,262 · 2024 $1,210 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $115 |
| Merck Sharp & Dohme LLC | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Edwards Lifesciences Corporation | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Impulse Dynamics (USA) Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
Products named: JARDIANCE, ENTRESTO, VERQUVO, FARXIGA, ONPATTRO, LifeVest, Optimizer, Kerendia.
Industry payments across NJ — which companies pay providers there.
